Corbus Pharmaceuticals Holdings, Inc.
Symbol: CRBP (NASDAQ)
16.60
▼ (-4.49%) -0.780
Company Description:
Corbus Pharmaceuticals Holdings Inc is a precision oncology company with a diversified portfolio and is committed to helping people defeat serious illness by bringing scientific approaches to well-understood biological pathways. The company's development pipeline includes; CRB-701, a next-generation antibody-drug conjugate (ADC) that targets the expression of Nectin-4 on cancer cells to release a cytotoxic payload, CRB-601, an anti-integrin monoclonal antibody that blocks the activation of TGF expressed on cancer cells, and CRB-913 a second-generation peripherally restricted CB1 receptor inverse agonist designed to treat obesity.
Key Stats
- Today's Open: $17.38
- Today's High: $17.585
- Today's Low: $16.52
- Today's Volume: 188.78K
- Yesterday Close: $17.38
- Yesterday High: $18
- Yesterday Low: $17
- Yesterday Volume: 188.55K
- Last Min Volume: 10
- Last Min High: $16.6
- Last Min Low: $16.6
- Last Min VWAP: $16.6
Company Profile
- Name: Corbus Pharmaceuticals Holdings, Inc.
- Website: https://www.corbuspharma.com
- Listed Date: 2014-10-24
- Location: NORWOOD, MA
- Market Status: Active
- CIK Number: 0001595097
- SIC Code: 2834
- SIC description: PHARMACEUTICAL PREPARATIONS
- Market Cap: $213.00M
- Round Lot: 100
- Outstanding Shares: 12.26M
- Asset Type: CS
RECENT FILINGS FOR CRBP
| Filing Date | Filing Type | Format |
|---|---|---|
| 2025-10-24 | 144 | View |
| 2025-10-24 | 144 | View |
| 2025-10-21 | 4 | View |
| 2025-10-20 | 8-K | View |
| 2025-09-16 | 8-K | View |
| 2025-08-05 | 10-Q | View |
| 2025-08-05 | 8-K | View |
| 2025-07-29 | SCHEDULE 13G/A | View |
| 2025-07-16 | SCHEDULE 13G/A | View |
| 2025-06-02 | 4 | View |
| 2025-06-02 | 4 | View |
| 2025-06-02 | 4 | View |
| 2025-06-02 | 4 | View |
| 2025-06-02 | 4 | View |
| 2025-06-02 | 4 | View |
| 2025-05-19 | 8-K | View |
| 2025-05-06 | 10-Q | View |
| 2025-05-06 | 8-K | View |
| 2025-04-01 | ARS | View |
| 2025-04-01 | DEFA14A | View |
Latest News on CRBP